Choroideremia Research
Choroideremia natural history studies
We are enrolling qualified patients with choroideremia in order to measure disease progression in a group of patients with this disease.
Choroideremia gene therapy trials
Qualifying patients may enter a gene therapy trial in an attempt to slow or halt the progression of Choroideremia
In order to be seen at the Retina Foundation of the Southwest, you must have a referral from your ophthalmologist.
If you have a question related to choroideremia, please contact us at 214-363-3911.

Related Articles
Children With Amblyopia and Strabismus Take Longer To Complete Answer Forms Recently@Retina Newsletter December 2024 Rose-Silverthorne Retinal Degenerations Lab to Conduct Natural History Study of Usher Syndrome Retina Foundation Presents New Data & Conclusions at ARVO 2018 Measuring the Release of A Therapeutic Drug in a Controlled Lab Setting